Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
Clinical trial NCT01349283 · COMPLETED
Trial details
- NCT number
- NCT01349283
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 1738
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.